AwesomeAvani

RYTM Biotech Penny Anti-Obesity LONG

Panjang
AwesomeAvani Telah dikemas kini   
BATS:RYTM   Rhythm Pharmaceuticals, Inc.
RYTM did a 120% run in November and December and then pivoted to start the year. It competes

in the anti-obesity drug space which is all the rage right now and has snack food manufactures

freaking out. The retrace was a shallow one in a sign of strength finding support at the 0.382

retracement level and then pivoting into a reversal in the past week. The dual TF RSI shows

the resurgence of bullish momentum. Earnings were okay, but not great. An FDA approval to add

to the mix of meds and lower their price in the competition may send RHYTHM into

launch mode. RYTM did 10% today such is the life of highly volatile penny stocks in what is

considered to be the likely hottest sector of the year. I will look toward OTM call options

for February 16th presently priced at about $200 per contract and a couple of shares shorted

to provide some hedging. Looking for 100% in 2-3 weeks. Will close 1/2 the position a few days

before upcoming earnings.
Dagangan aktif:
Dagangan aktif:
Holding full position during consolidation.
Dagangan aktif:
Finally another leg higher. Holding full position.
Penafian

Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.